Search

Search Constraints

You searched for: Author/Creator Latagliata, Roberto

Search Results

1. Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols. (2nd November 2021)

2. Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1‐negative Myeloproliferative Neoplasms Latium Group". (16th June 2020)

3. Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN. Issue 8 (August 2015)

4. Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN. Issue 8 (August 2015)

5. Balanced and unbalanced chromosomal translocations in myelodysplastic syndromes: clinical and prognostic significance. Issue 14 (5th December 2020)

6. Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors. (5th July 2017)

7. Bosutinib in the real‐life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine‐kinase inhibitors. Issue 3 (13th March 2021)

8. Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase. (18th September 2015)

9. Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome. (7th February 2017)

10. Chronic phase chronic myeloid leukemia patients who failed interferon alpha and switched to imatinib: Long‐term 9‐year follow‐up of 134 patients. Issue 5 (30th March 2015)